nsaids
DESCRIPTION
THIS LECTURE CONTAINS PRESENTATION ON NSAIDS.DO SEND YOUR SUGGESTIONS.TRANSCRIPT
![Page 1: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/1.jpg)
NSAIDS
Dr.B.M.PUROHITAssistant Professor (Pharmacology)
P.D.U.MEDICAL COLLEGE,Rajkot (GUJARAT). 360001
![Page 2: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/2.jpg)
This powerpoint works best only if you are using office-2007.Some features of the given presentation may not work if you are using older version(97-2003) of office.
![Page 3: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/3.jpg)
• This is not a LECTURE……………this is a discussion… sadly … not live !!!
• Objective is not to bombard information but to develop concepts….
• So.. Get ready to chat !!
![Page 4: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/4.jpg)
!!! GO SLOW !! Best luck !!!
![Page 5: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/5.jpg)
INTRODUCTION• NSAIDs means.. “Non Steroidal Anti Inflammatory Drugs”• If you want to study ANTI INFLAMMATORY drugs , you should know ……• What is inflammation ?...
– “Response of the body to injurious stimuli”– So it is beneficial.
• Than why it is required to be suppressed ?– Because at times it can be in EXAGGERATED form and can be….– Harmful to body– Extremely disturbing to the patient
5
![Page 6: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/6.jpg)
Which are the features of inflammation… ?
1. Heat/fever 2. Swelling 3. Pain 4. Redness5. Loss of function
NSAIDS addresses mainly FEVER, PAIN AND SWELLING.Redness is not a problem from functional point of view.Loss of function is usually restored when FEVER , PAIN and SWELLING are
taken care of “if” it is due to those features..Loss of function because of permanent fibrosis can not be reversed.
IN ONE WAY, fever and pain are beneficial ….. HOW ?
6
![Page 7: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/7.jpg)
7
So both phenomenon are beneficial
![Page 8: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/8.jpg)
• But when these reflexes are EXAGGERATED it is required to be suppressed because ……
• RAISED TEMPERATURE ….– May make a person incapable for doing his job.– May inactivate several enzymes required to
maintain normal metabolism.– In extreme cases…interfere with the state of
consciousness.
• EXCESSIVE PAIN …– May interfere with the quality of life.– May frighten the patient.– In extreme cases …may produce shock …
8
![Page 9: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/9.jpg)
9
![Page 10: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/10.jpg)
• We will study both pathways…• Now get ready for a LONG CHAIN OF
CHEMICAL REACTIONS …• This chemical reactions are IMPORTANT..• Products of this pathway PRODUCE
NUMEROUS ACTIONS.• They are the sites of pharmacological
intervention.
10
![Page 11: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/11.jpg)
11
PGG2
MEMBRANE PHOSPHOLIPID
ARACHIDONIC ACID
12-HPETE
PHOSPHOLIPASE
CHEMICAL AND MECHANICAL
STIMULIE
5-HPETE
PGH2
ISOMERASE
PGD2 PGE2 PGF2α
THROMBOXANE SYNTHEASE
PROSTACYCLINE SYNTHEASE
TXA2
TXB2
PGI2
LTB4
LTA4
LTC4
LTD4
LTE4LTF4
CYCLOXYGENASE PATHWAY LIPOXYGENASE
PATHWAY
15-HPETE
![Page 12: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/12.jpg)
• Was it frightening…. ?• DEFINATETLY NEED A REVISION…….. RIGHT ?
12
![Page 13: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/13.jpg)
13
PGG2
MEMBRANE PHOSPHOLIPID
ARACHIDONIC ACID
12-HPETE
PHOSPHOLIPASE
CHEMICAL AND MECHANICAL
STIMULIE
5-HPETE
PGH2
ISOMERASE
PGD2 PGE2 PGF2α
THROMBOXANE SYNTHEASE
PROSTACYCLINE SYNTHEASE
TXA2
TXB2
PGI2
LTB4
LTA4
LTC4
LTD4
LTE4LTF4
CYCLOXYGENASE PATHWAY LIPOXYGENASE
PATHWAY
15-HPETE
![Page 14: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/14.jpg)
Summary of the chart…• Cycloxygenase pathway generates …
– TXA2.– PGD2– PGE2– PGF2α– PGI2.
• How to remember it ?• Alphabetical order is … DEFGH• Here first … G & H and then D E F.
• Lipoxygenase pathway generates – 12 HPETE through 12-lipoxygenase– 15 HPETE through 15-lipoxygenase– 5-HETE through 5-Lipoxygenase
• 5-HETE subsequently produces …– LTA4 LTB4– LTA4 LTC4 LTD4 LTE4
14
![Page 15: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/15.jpg)
• So that was CHEMISTRY part of inflammation…
• Now their FUNCTIONAL part….• There are so many mediators of
inflammation..• Which causes numerous effects….
15
![Page 16: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/16.jpg)
16
They are Opposite !!! Store it in your mind !!!
![Page 17: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/17.jpg)
17
It is not possible to remember
everything !! Don’t worry !!
![Page 18: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/18.jpg)
• Its not possible to remember ALL THE EFFECTS of ALL THE MEDIATORS.
• Just try to remember the NAMES OF MEDIATORS and
• MAJOR EFFECT produced by it.
18
![Page 19: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/19.jpg)
PAIN
• Unpleasant experience• Protective reflex
– Warning bell of tissue damage !!
• Interferes with Quality Of Life.• Two components
– Sensations peripheral component– Perception central component
19
![Page 20: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/20.jpg)
CLASSIFICATION
• Superficial or cutaneus pain• Deep pain from muscle,joints,ligaments and
bones.• Visceral pain-(spasm,infla.,ischemia,stim. Of
nerve endings)• Deafferentiation pain /neuropathic pain-
(damage to axons or nerve membranes)• Psychological/Functional
20
![Page 21: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/21.jpg)
• Now move ahead for “PAIN PATHWAY”• 1ST Slide shows afferent pathway. ( periphery to
centre).• 2nd Slide shows efferent pathway.(centre to
periphery).• Again you are not expected to remember it, but you
should have an idea about nuts and bolts of pain circuits.
21
![Page 22: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/22.jpg)
22
![Page 23: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/23.jpg)
23
SOMATIC SENSORY CORTEX
`
Amygdala Hypothalamus
Midbrain periaqueductal gray matter
Parabrachialnucleus
Medullary Reticular formation
Locuscerulous
Raphe nuclei
Dorsal horn of the spinal cord
Anterolateral
System
![Page 24: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/24.jpg)
• Prostaglandins (PGS) sensitize the nerve endings….
• To the nociceptive stimuli …….• Caused by …….• Histamine…… and• Bradykinin.
24
![Page 25: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/25.jpg)
25
Pharmacological/Physiological EffectsI. Cardiovascular System
![Page 26: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/26.jpg)
II. PLATELETS
26
![Page 27: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/27.jpg)
NORMALLY IN GIT…
27
NSAIDS blocks
this
So PGS have PROTECTIVE effect on GIT
![Page 28: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/28.jpg)
RESPIRATORY SYSTEM
28
![Page 29: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/29.jpg)
GI TRACT
29
![Page 30: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/30.jpg)
30
V. Reproductive Organs
![Page 31: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/31.jpg)
31
VI. Pain and Inflammation1. PGE2, PGI2, LTB4: sensitize nerve endings to painful
stimuli.2. Hyperemia, Edema, Hotness due to increased
eicosanoids at inflammation sites.3. LTB4: chemotactic factor for neutrophils and
mononuclear cells. Promotes aggregation and degranulation of PMN’s, adhesion to vessel wall and migration
Pharmacological/Physiological Effects
![Page 32: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/32.jpg)
PGS produce PAIN… how ?
32
![Page 33: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/33.jpg)
PGS produces FEVER….. How ?
• Hypothalamus contains thermoregulatory centre
• Maintains balance between heat production and heat loss
• It regulates heat dissipating mechanisms
33
![Page 34: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/34.jpg)
34
![Page 35: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/35.jpg)
PGs PRODUCES INFLAMMATION … HOW ?
35
INFLAMMATION
![Page 36: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/36.jpg)
Mechanism Of Action : NSAIDS
36
MOST IMPORTANT MECHANISM
Efficacy of these mechanisms is
doubtful..So you are not
required to remember
everything!! Just keep in mind that such mechanisms
exist !!
![Page 37: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/37.jpg)
COX-1• Physiologically expressed• Maintains the normal
(house keeping) function.• Expressed in ..
– Platelets – GIT
COX-2• Induced in pathological
states (mostly)• Physiologically expressed in
kidney.
37
So NON SPECIFIC NSAIDS
produces bleeding
tendency and peptiuc ulcer
![Page 38: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/38.jpg)
38
![Page 39: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/39.jpg)
39
![Page 40: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/40.jpg)
SALICYLATES
40
![Page 41: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/41.jpg)
Analgesic activity
• No impairment of mental activity. No hypnosis
• Major component peripheral action• Minor component central action
• Can be combined with opioids
• ONLY NSAID THAT BLOCKS THE COX ENZYME IRRERVERSIBLY
• NSAIDS suppresses the pain arising out of bones and joints exception DYSMENORRHEA 41
![Page 42: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/42.jpg)
NSAIDS blocks..
42
REDUCES THE INTENSITY OF
PAIN
![Page 43: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/43.jpg)
ANTIPYRETIC ACTIVITY
• Hypothalamus contains thermoregulatory centre
• Maintains balance between heat production and heat loss
• It regulates heat dissipating mechanisms
43
Reduces fever due to inflammation. But not due to…1.Heat stroke2.Exercise induced/Physiological diurnal variation in temperature
NSAIDS inhibits PGE2 synthesis and
reduces fever
![Page 44: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/44.jpg)
GIT
44
So Use aspirin with Plenty of water or after foodMilkAlkaliSoluble of buffered aspirin
![Page 45: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/45.jpg)
ANTIINFLAMMATORY ACTIVITY
• Decrease PG in peripheral tissue• Reduce capillary permeability• Inhibition of neutrophil aggregation and
activation• Inhibition of activated kallikrein from inactive
plasma and leucocyte kallikrein.• Inhibite mucopolysaccheride biosynthesis
reduce edema.
45
![Page 46: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/46.jpg)
BLOOD AND PLATELETS
• Antiplatelet action• Irreversibe COX inhibition• 75-150 mg OD• Platelet activity starts after 7-10 days when
new platelets are synthesized.• IN RHEU. FEVER aspirin reduces WBC count
and ESR.• Decrease fibrinogen level
46
![Page 47: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/47.jpg)
URICOSURIC ACTION
• Urate present in glomerular filtrate is reabsorbed by proximal tubule
• Excretion occurs because of tubular secretion.
47
![Page 48: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/48.jpg)
PHARMACOKINETICS• ABSORPTION :
– Skin– GIT
• Particle size• pH• Solubility of salicylate preparation• Presence of food
• DISTRIBUTION:– 80% Albumin– Achieves significant concentration in saliva,milk,spinal,synovial fluid, peritoneal fluid
and in RBCs.– HIGH AMOUNT liver, heart and muscle– SMALL AMOUNT brain.
48
So little central action.
![Page 49: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/49.jpg)
• MetabolismAspirin
• 300-600 mg dose : 1st order kinetics• 1-2 gm dose : zero order kinetics toxicity
49
SalicylateDeacetylation
Salicylic acid
PHARMACOKINETICS
![Page 50: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/50.jpg)
• EXCRETION :
50
Salicylate
Glycine conjugation
Glucuronic acid conjugation
Oxidized to Gentisic acid
PHARMACOKINETICS
![Page 51: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/51.jpg)
• INTOLERANCE :» HS reaction.» Angioedema & anaphylactic symptoms adrenalin» G6PD deficiency hemolytic anaemia»
•
ADVERSE REACTION
51
Cell Membrane Phospholipids
Arachidonic Acid
Prostaglandin H2
Phospholipase A2
Cyclooxygenase I&II
Leucotriens
Inflammation Bronchospasm
NSAIDS
![Page 52: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/52.jpg)
52
![Page 53: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/53.jpg)
GIT
53
![Page 54: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/54.jpg)
KIDNEY
54
![Page 55: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/55.jpg)
REYE’S SYNDROME
55
![Page 56: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/56.jpg)
56
Aspirin Toxicity - Salicylism
![Page 57: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/57.jpg)
MANAGEMENT OF SALICYLISM• Hospitalization• Gastric lavage• Rx of
– Hyperthermia– Dehydration– Hypokalamia– Acid base disturbances– Ketosis
• Alkalization• Vit,K, BLOOD TRANSFUSION
57
![Page 58: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/58.jpg)
USES
• LOCAL APPLICATION– Keratolytic– Fungistatic– Antiseptic– Counter irritant– IBS
58
![Page 59: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/59.jpg)
• ANALGESIC – Musculoskeletal pain– Dysmenorrhea
• ANTIPYRETIC– Remember, it reduces fever due to inflammation
but not due to ….?????
• ANTIINFLAMMATORY– Arthritis– Fibromyositis
59
![Page 60: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/60.jpg)
60
Antirheumatic action
ANTIRHEUMATIC
![Page 61: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/61.jpg)
61
![Page 62: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/62.jpg)
ANTIPLATELET ACTION – Platelets aggregates and provides the nidus for thrombus formation.
– Platelet aggregation is prevented by PGI2 in circulation and
promoted by TXA2.
– Inhibition of TXA2 by Aspirin at LOWER DOSES (75-150 mg) reduce platelet aggregation.
– Platelet TXA2 remains irreversibly inhibited
– Only when new platelets are synthesized , platelet activity restarts (approx. 7-10 days)
– Stop aspirin one week prior to surgery.– Useful in …..thromboembolic disorders ( MI, TIA, Ischemic stroke, atherosclerotic PVDs)– Avoid aspirin in …..Liver damage Hypo prothombinemia Vit. K deficiency Haemophilia
62
![Page 63: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/63.jpg)
• PDA :– PG mediadted– IV administration of 0.1 to 0.2 mg/kg every 12 hours for three doses. – 70% success..– Primarily in premature infants who weigh between 500 and 1750 g, – Who have a hemodynamically significant patent ductus arteriosus, and– In whom other supportive maneuvers have been attempted.
• Several food allergy– PG mediadted
• Radiation induced diarrhoea– PGmediadted
• Local application in sunburn PG mediadted
• Systemic mastocytosis– Use with antihistaminics
• C0lon carcinoma – Familial adenomatous polyposis (fap)– Pgs involved in carcinogenesis– Inhibits angiogenesis
• Dysmenorrhoea :– Increase d PG in menstrual blood uterine cramps. 63
![Page 64: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/64.jpg)
NOW IT’S TIME TO REVISE• What is inflammation ?• Why it is required to be suppressed >?• How PAIN and FEVER and beneficial and how they are harmful ?• Following injury which chemical reactions are set off ?• What are the effects of PGD2,PGE2,PGF2α, PGI2, TXA2, LTA4 ?• How will you classify pain ?• Do your remember pain pathway ? If yes … good …if no … it’s ok.• What is the effect of different mediators on I.blood vessels, II. platelets, III. GIT, IV. respiratory
system and V. reproductive system ?• How PGS produces PAIN, FEVER and INFLAMMATION ?• Which are the mechanisms of action of NSAIDS ?• Which are the local actions of NSAIDS ?• How NSAIDS produces ANALGESIC, ANTIPYRETIC and ANTIINFLAMMATORY actions ?• How it produces anti platelet action ?• What is the effect of aspirin on urate levels ?• Which are the main ADRs of NSAIDS ? What are the pharmacological basis of the same ?• How they produces reye’ s syndrome ?• What is salicylism ? How will you treat it ?• Which are the uses of aspirin ? Which are the pharmacological basis of the same ?
64
![Page 65: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/65.jpg)
65
Diflunisal
• Cancer pain with bone metastases • For pain control in dental (third molar)
surgery. • 2% diflunisal oral ointment is a clinically useful
analgesic for painful oral lesions.
![Page 66: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/66.jpg)
PARACETAMOL• Analgesic • Antipyretic• Central action> Peripheral action• 10–15 mg/kg every 4 hours (maximum of 5 doses/24 hours)• NO
– GI disturbances Acid-base imbalance Electrolyte imbalance Impairment of clotting
• ADR :– Extremely safe drug. But rarely produces …. Hepatic toxicity
66
![Page 67: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/67.jpg)
67
Paracetamol overdose• Ingestion of >10g of paracetamol may be fatal• May be lower in chronic alcoholics or subjects with
underlying liver disease. Clinical featuresIn severe poisoning • Up to 24 hours - none or nausea and vomiting• > 24 hours - nausea and vomiting, right
upper quadrant pain, jaundice, encephalopathy
![Page 68: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/68.jpg)
NAC SUPPLIES GLUTATHIONES
so detoxifies toxic
metabolites !!
NAC “MAY”directly conjugates with
quinones/epoxide.
MAY BE… NAC has additional
antioxidant and antiinflammato
ry activity
![Page 69: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/69.jpg)
Management • Repeat blood paracetamol estimatations.
69
PARACETAMOL (acetaminophen)
![Page 70: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/70.jpg)
• Now we will discuss all the remaining NSAIDs..• Their
– MOA, – ADR, – USES
are more or less same.So we will only discuss differentiating points.Or something UNIQUE about that particular drug.You are not required to remember ALL THE DETAILS of ALL THE DRUGS.This list has been added only so that …. Presentation does not look
incomplete !!!! ????
70
![Page 71: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/71.jpg)
• PHENYLBUTAZONE & OXYPHENBUTAZONE– Now almost obsolated
• ANALGIN :– Fatal blood dyscrasias
• DICLOFENAC SODIUM:• Neutrophil chomotaxis and superoxide production is reduced• Hepatotoxicity more common than other NSAIDS.• Eye drops/Gel for solar keratosis (3%)/Rectal suppository for post op.
analgesia/Oral mouthwash/IM injection• ACECLOFENAC• More GI friendly• Some what selective on COX-2.• Enhancement of glycosaminoglycan synthesis chondroprotective
property.• MELOXICAM• Preferential COX-2 inhibitor
71
![Page 72: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/72.jpg)
72
• ETODOLAC • Postoperative pain relief after coronary artery bypass operations• IBUPROFEN • Oral • Topical cream preparation -primary knee osteoarthritis • Patent ductus arteriosus in preterm infants • FENOPROFEN• The NSAID most closely associated with interstitial nephritis • FLURBIPROFEN• Also affect TNF-a and nitric oxide synthesis?? • 200-400 mg/d • Ophthalmic formulation for inhibition of intraoperative miosis • Flurbiprofen intravenously has been found to be effective for perioperative
analgesia in minor ear, neck, and nose surgery and in lozenge form for sore throat.
• Rarely with cogwheel rigidity, ataxia, tremor, and myoclonus
![Page 73: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/73.jpg)
• PIROXICAM • A nonselective COX inhibitor that at high concentrations also inhibits polymorphonuclear
leukocyte migration, decreases oxygen radical production, and inhibits lymphocyte function. • Decreases the production of IgM rheumatoid factor.• USES :
– Same • TENOXICAM
– SAME ….• INDOMETHACIN
• PDA – 0.1-0.2 mg/kg /12 hr X 3 times. • Ophthalmic preparation -- conjunctival inflammation reduce pain after traumatic
corneal abrasion • Gingival inflammation is reduced after administration of indomethacin oral rinse. • Malignancy induced fever.• frontal headache & other CNS side effects. C/I in psychiatric illness or epilepsy.• HYPERKALAMIA
• KETOROLAC • Replace morphine in some situations involving mild to moderate postsurgical pain. • ORAL/IM/IV/EYE DROP
–73
![Page 74: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/74.jpg)
• NABUMETONE– Pseudoporphyria and photosensitivity
• NAPROXEN – Oral suspension/SR preperation/Eye drops
• SULINDAC :– Suppresses familial intestinal polyposis – It may inhibit the development of colon, breast, and prostate cancer – Sulfa like reaction
• NIMESULIDE• Weak PG synthesis inhibitor. Relative COX-2 inhibitor• Other mechanisms like …
– inhibition of neutrophil activation– Reduced generation of superoxide– Inhibition of PAF synthesis & TNF α release.– Free radicle scavanging– Inhibition of metalloproteinase activity.– possibly activation of glucocorticoid receptors???
74
![Page 75: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/75.jpg)
75
SELECTIVE COX-2 INHIBITORS
• CELECOXIB• ROFECOXIB• VALDECOXIB• ETOROCOXIB• LUMERACOXIB• PARACOXIB– only selective COX-2 inhibitor for
parental use.
BANNED BECAUSE OF CARDIOVASCULAR MORATLITY
![Page 76: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/76.jpg)
76
Advantages• No ADR like
– GI ulceration– Bleeding tendency
Disadvantage– Increases cardio vascular
mortality because of inhibition of endothelial PGI2 production without effect on platelet TXA2 synthesis.
– ??Incomplete suppression of inflammation.
– COX-2 is constitutively expressed in kidney so nephrotoxicity can not be avoided. Na+ and Water retention,edema,HT,CHF may be ppted.
![Page 77: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/77.jpg)
77
• CELECOXIB– GI friendly– Sulfalike reaction– Edema and HT
• ETOROCOXIB– Maximum COX2: COX 1 activity ration– OA – 60 mg OD– RA - 90 mg OD– Acute gouty arthritis 120 mg OD– Acute musculoskeletal pain- 60 mg OD– ADR :
• Dry mouth• Aphthous ulcer• Taste disturbnaces• Paraesthesia
• Lumiracoxib :– Its acidic nature allows it to penetrate well into areas of inflammation– The half-life in synovial fluid is considerably longer than in plasma.– Once-daily dosing.– 900-mg dose.– Cardiovascular safety questionable….– Gi safety promised…
![Page 78: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/78.jpg)
78
![Page 79: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/79.jpg)
TOPICAL NSAIDS• Used for RA,OA,musculoskeletal pain,Soft Tissue Injury etc.• Advantage (???):
– ??? High local levels????? may be better therapeutic efficacy.– Low systemic levels GI safety.
• DILEMMA , whether the effect is ….– Due to drug ?– Due to placebo ?– Due to irritant present in ointments ?– Due to concomitant oral NSAID?
• EVIDENCES AVAILABLE SO FAR ….– Slow topical absorption (~10 times than oral)– Highest blood levels remains 15% below the same dose given orally.– Upto 4-6 mm( Dermis) high concentraion.– At 25 mm (muscle ) concentration is low and same as blood.
• MARKED INTERINDIVIDUAL VARIATION( 18-92%) 79
![Page 80: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/80.jpg)
80
![Page 81: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/81.jpg)
Selection of NSAID
81
![Page 82: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/82.jpg)
82
![Page 83: NSAIDS](https://reader038.vdocuments.net/reader038/viewer/2022103013/54580819af79596b478b504f/html5/thumbnails/83.jpg)
• DO SEND YOUR– Comments– Suggestions – Queries– Grievances on…
• [email protected] or • +91 9725024978• Chat live on yahoo some day: purohit_bhargav. • When you send email do SEND YOUR DETAILS ( e.g. Name,Institute, your
designation (if you are a faculty) etc) and in subject line mention the topic’s name.